Table 4.

Tumor shrinkage in Japanese vs. non-Japanese patients

	Japanese				Non-Japanese
	Totala	Axitinib titration	Placebo titration	Non-randomized	Totalb,c,d	Axitinib titrationd	Placebo titrationc,d	Non-randomizedd
	n = 44	n = 6	n = 5	n = 32	n = 169	n = 50	n = 51	n = 59
Change from baseline in sum of tumor diameter for target lesion (%)
Mean	−40.2	−41.6	−27.5	−43.0	−33.9	−33.8	−26.1	−42.6
SD	23.2	19.5	16.3	23.9	37.3	41.9	36.9	31.7

^aIncludes one patient who received treatment and withdrew during the lead-in period.

^bIncludes nine patients who received treatment and withdrew during the lead-in period.

^cOne patient in placebo-titration arm did not have measurable disease at baseline.

^dData are missing for 12, one, three and two patients in the total, axitinib titration, placebo titration and non-randomized arm, respectively.